Inventor · disambiguated record
Raymond Schuch
Also filed as: SCHUCH RAYMOND
23 granted patents·25 pending applications·122 citations·filing 1999–2024
94Inventor score
Files withCONTRAFECT CORP31UNIV ROCKEFELLER10AUROBAC THERAPEUTICS SAS2SCHUCH RAYMOND2FISCHETTI VINCENT A1
Top patents by PatentIndex Score
48 records- 0197US10988520B2Lysin-antimicrobial peptide (AMP) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereofCONTRAFECT CORP·Filed 2020·Granted Apr 27, 2021·5 cites·20 claims
- 0294US10744189B2Lysin polypeptides active against Gram-negative bacteriaCONTRAFECT CORP·Filed 2016·Granted Aug 18, 2020·8 cites·14 claims
- 0394US7638600B2Lytic enzymes and spore surface antigen for detection and treatment of Bacillus anthracis bacteria and sporesUNIV ROCKEFELLER·Filed 2005·Granted Dec 29, 2009·24 cites·15 claims
- 0494US7582291B2Bacteriophage lysins for Enterococcus faecalis, Enterococcus faecium and other bacteriaUNIV ROCKEFELLER·Filed 2006·Granted Sep 1, 2009·32 cites·27 claims
- 0592US11413334B2Lysin polypeptides active against Gram-negative bacteriaCONTRAFECT CORP·Filed 2020·Granted Aug 16, 2022·2 cites·13 claims
- 0688US7402309B2Phage-associated lytic enzymes for treatment of Bacillus anthracis and related conditionsUNIV ROCKEFELLER·Filed 2004·Granted Jul 22, 2008·26 cites·20 claims
- 0786US11773140B2Gram-negative lysin-antimicrobial peptide (AMP) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof in human serumCONTRAFECT CORP·Filed 2019·Granted Oct 3, 2023·3 cites·47 claims
- 0885US9499594B2Biofilm prevention, disruption and treatment with bacteriophage lysinCONTRAFECT CORP·Filed 2013·Granted Nov 22, 2016·6 cites·20 claims
- 0985US2025064902A1Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited therebyAUROBAC THERAPEUTICS SAS·Filed 2024·Application pending·0 cites
- 1080US2023277617A1Biofilm prevention, disruption and treatment with bacteriophage lysinCONTRAFECT CORP·Filed 2022·Application pending·0 cites
- 1177US10590403B2Acinetobacter lysinsUNIV ROCKEFELLER·Filed 2015·Granted Mar 17, 2020·3 cites·13 claims
- 1277US7838255B2Nucleic acids and polypeptides of C1 bacteriophage and uses thereofUNIV ROCKEFELLER·Filed 2009·Granted Nov 23, 2010·2 cites·6 claims
- 1377US2023050560A1Lysin polypeptides active against gram-negative bacteriaCONTRAFECT CORP·Filed 2022·Application pending·0 cites
- 1476US12144845B2Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited therebyAUROBAC THERAPEUTICS SAS·Filed 2022·Granted Nov 19, 2024·0 cites·14 claims
- 1575US9889181B2Bacteriophage lysin and antibiotic combinations against gram positive bacteriaCONTRAFECT CORP·Filed 2013·Granted Feb 13, 2018·2 cites·12 claims
- 1674US7582729B2Nucleic acids and polypeptides of C1 bacteriophage and uses thereofUNIV ROCKEFELLER·Filed 2004·Granted Sep 1, 2009·2 cites·2 claims
- 1772US11524046B2Biofilm prevention, disruption and treatment with bacteriophage lysinCONTRAFECT CORP·Filed 2019·Granted Dec 13, 2022·0 cites·43 claims
- 1871US12121568B2Identification of lysins and derivatives thereof with bactericidal activity against Pseudomonas aeruginosaCONTRAFECT CORP·Filed 2018·Granted Oct 22, 2024·1 cites·36 claims
- 1971US2022402984A1Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereofCONTRAFECT CORP·Filed 2022·Application pending·0 cites
- 2070US8389469B2Bacteriophage lysins for Bacillus anthracisYOONG PAULINE·Filed 2006·Granted Mar 5, 2013·2 cites·15 claims
- 2170US2024018192A1Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereofCONTRAFECT CORP·Filed 2023·Application pending·0 cites
- 2269US2021128696A1Bacteriophage lysin and antibiotic combinations against gram positive bacteriaCONTRAFECT CORP·Filed 2021·Application pending·0 cites
- 2368US11357833B2Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited therebyCONTRAFECT CORP·Filed 2016·Granted Jun 14, 2022·0 cites·17 claims
- 2468US9404922B2Recombinant phages and proteinsUNIV ROCKEFELLER·Filed 2014·Granted Aug 2, 2016·1 cites·4 claims
- 2568US2021008175A1Bacteriophage lysin and antibiotic combinations against gram positive bacteriaCONTRAFECT CORP·Filed 2020·Application pending·0 cites
- 2666US10813983B2Bacteriophage lysin and antibiotic combinations against gram positive bacteriaCONTRAFECT CORP·Filed 2013·Granted Oct 27, 2020·0 cites·8 claims
- 2764US11180744B2Acinetobacter lysinsUNIV ROCKEFELLER·Filed 2019·Granted Nov 23, 2021·0 cites·20 claims
- 2864US8580553B2Phage-associated lytic enzymes for treatment of Bacillus anthracis and related conditionsFISCHETTI VINCENT A·Filed 2008·Granted Nov 12, 2013·0 cites·30 claims
- 2964US2021147498A1Use of gram-negative lysin-antimicrobial peptide (amp) polypeptide constructs in pulmonary surfactant and biofilmsCONTRAFECT CORP·Filed 2020·Application pending·0 cites
- 3061US2021363511A1Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereofCONTRAFECT CORP·Filed 2019·Application pending·0 cites
- 3160US2024181022A1Amurins lysins, and lysin-antimicrobial peptide (amp) constructs active against gram-negative bacteriaCONTRAFECT CORP·Filed 2022·Application pending·0 cites
- 3257US10851401B2Broth microdilution method for evaluating and determining minimal inhibitory concentration of antibacterial polypeptidesCONTRAFECT CORP·Filed 2017·Granted Dec 1, 2020·0 cites·16 claims
- 3357US2018221456A1Bacteriophage lysin and antibiotic combinations against gram positive bacteriaSCHUCH RAYMOND·Filed 2017·Application pending·0 cites
- 3456US2023277632A1MODIFIED PlySs2 LYSINS AND ANTIBIOTIC COMBINATIONS FOR USE AGAINST GRAM-POSITIVE BACTERIACONTRAFECT CORP·Filed 2021·Application pending·0 cites
- 3555US2017127683A1Biofilm prevention, disruption and treatment with bacteriophage lysinSCHUCH RAYMOND·Filed 2016·Application pending·0 cites
- 3654US2021324359A1Use of gram-negative lysin-antimicrobial peptide (amp) polypeptide constructs in treating endocarditisCONTRAFECT CORP·Filed 2020·Application pending·0 cites
- 3754US2022411473A1Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereofCONTRAFECT CORP·Filed 2020·Application pending·0 cites
- 3854US2022024992A1Compositions and methods comprising lysocins as bioengineered antimicrobials for use in targeting gram-negative bacteriaUNIV ROCKEFELLER·Filed 2019·Application pending·0 cites
- 3952US2021330738A1Antimicrobial, bacteriophage-derived polypeptides and their use against gram-negative bacteriaCONTRAFECT CORP·Filed 2019·Application pending·0 cites
- 4052US2022401514A1Antimicrobial, bacteriophage-derived polypeptides and their use against gram-negative and acid-fast bacteriaCONTRAFECT CORP·Filed 2020·Application pending·0 cites
- 4151US2022160842A1Method of treating infective endocarditisCONTRAFECT CORP·Filed 2020·Application pending·0 cites
- 4251US2022193186A1Method of treating and preventing bone and joint infectionsCONTRAFECT CORP·Filed 2020·Application pending·0 cites
- 4349US2022023399A1Blood component potentiation of lytic protein anti-bacterial activity and methods and uses thereofCONTRAFECT CORP·Filed 2018·Application pending·0 cites
- 4446US2022160843A1Lysins and derivatives thereof with bactericidal activity against pseudomonas aeruginosa, in the presence of human serumCONTRAFECT CORP·Filed 2020·Application pending·0 cites
- 4546US2021260070A1Lysin cf-301 resensitizes methicillin-resistant staphylococcus aureua (mrsa) to penicillin derivatives and first generation cephalosporinsCONTRAFECT CORP·Filed 2019·Application pending·0 cites
- 4646US2021032294A1MODIFIED PlySs2 LYSINS AND USES THEREOFCONTRAFECT CORP·Filed 2019·Application pending·0 cites
- 4743US2014073639A1Inhibition of antimicrobial targets with reduced potential for resistanceUNIV ROCKEFELLER·Filed 2013·Application pending·0 cites
- 4830US6342352B1Method of detecting shigella and shigella mxiM DNAJACKSON H M FOUND MILITARY MED·Filed 1999·Granted Jan 29, 2002·3 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when Raymond Schuch files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →